Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood

• Publication date

  2003-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2002-10-3058PMID 12609831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The pre-B cell receptor signaling for apoptosis is negatively regulated by Fc gamma RIIB.

  2002cited by this paper
• The Pre-B Cell Receptor Signaling for Apoptosis Is Negatively Regulated by FcγRIIB1

  2002cited by this paper
• Human eosinophils, basophils, and HMC-1 cells express both short and long splice variants of siglec-8

  2002cited by this paper
• Human eosinophils express two Siglec-8 splice variants.

  2002cited by this paper
• Allergy and allergic diseases. First of two parts.

  2001cited by this paper
• Eosinophil trafficking to sites of allergic inflammation

  2001cited by this paper
• Siglecs, sialic acids and innate immunity.

  2001cited by this paper
• Ceramide Enables Fas to Cap and Kill*

  2001cited by this paper
• The Pre-B Cell Receptor Signaling for Apoptosis Is Negatively Regulated by Fc RIIB

  2001cited by this paper
• Signaling pathways and effector mechanisms pre-programmed cell death.

  2001cited by this paper
• Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis*

  2001cited by this paper
• Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells

  2001cited by this paper
• A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.

  2001cited by this paper
• Linkage to atopy on chromosome 19 in north‐eastern Italian families with allergic asthma

  2001cited by this paper
• Allergy and allergic diseases. Second of two parts.

  2001cited by this paper
• Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.

  2001cited by this paper
• p75/AIRM1 and CD33, two sialoadhesin receptors that regulate the proliferation or the survival of normal and leukemic myeloid cells

  2001cited by this paper
• Siglec-8

  2000cited by this paper
• Molecular characterization of a Siglec8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec8 gene.

  2000cited by this paper
• olecular Characterization of a Siglec 8 Variant ontaining Cytoplasmic Tyrosine-Based Motifs , nd Mapping of the Siglec 8 Gene

  2000cited by this paper
• Genome screen for asthma and related phenotypes in the French EGEA study.

  2000cited by this paper
• Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils.

  2000cited by this paper
• Effect of IL‐5, glucocorticoid, and Fas ligation on Bcl‐2 homologue expression and caspase activation in circulating human eosinophils

  2000cited by this paper
• Ligation of Fc gamma RII (CD32) pivotally regulates survival of human eosinophils.

  1999cited by this paper
• The sialoadhesin CD33 is a myeloid‐specific inhibitory receptor

  1999cited by this paper
• Ligation of FcγRII (CD32) Pivotally Regulates Survival of Human Eosinophils

  1999cited by this paper
• Association of Tyrosine Phosphatases SHP-1 and SHP-2, Inositol 5-Phosphatase SHIP with gp49B1, and Chromosomal Assignment of the Gene*

  1998cited by this paper
• The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

  1998cited by this paper
• Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

  1998cited by this paper
• Siglecs: a family of sialic-acid binding lectins.

  1998cited by this paper
• Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5.

  1998cited by this paper
• Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma.

  1998cited by this paper
• A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils.

  1998cited by this paper
• The major SHP-1-binding, tyrosine-phosphorylated protein in macrophages is a member of the KIR/LIR family and an SHP-1 substrate

  1998cited by this paper
• Genome-Wide Search for Asthma Susceptibility Loci in a Founder Population

  1998cited by this paper
• Eosinophilia.

  1998cited by this paper
• Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line.

  1997cited by this paper
• Early detection of apoptosis using a fluorescent conjugate of annexin V.

  1997cited by this paper
• A Novel Phosphotyrosine Motif with a Critical Amino Acid at Position −2 for the SH2 Domain-mediated Activation of the Tyrosine Phosphatase SHP-1*

  1997cited by this paper
• The molecular biology of apoptosis.

  1996cited by this paper
• Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor.

  1996cited by this paper
• Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.

  1996cited by this paper
• Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro.

  1995cited by this paper
• Immunological aspects of allergic asthma.

  1994cited by this paper
• Glucocorticoids inhibit cytokine-mediated eosinophil survival.

  1991cited by this paper
• Interactions between human eosinophils and schistosomula of schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence

  1979cited by this paper

• Eosinophils: Pathological Mechanisms and Novel Targeted Therapeutic Strategies Across Multiple Disease Spectrums.

  2026cites this paper
• Low‐Density Neutrophils: Enigmatic Cells in Health and Disease

  2025cites this paper
• Regulation of eosinophil recruitment and heterogeneity during allergic airway inflammation

  2025cites this paper
• The Forgotten Innate Immune Cells: Unraveling Their Prospective Interactions with Nanomaterials

  2025cites this paper
• Enhanced Siglec-8 and HLA-DR and Reduced CRTH2 Surface Expression, Highlight a Distinct Phenotypic Signature of Circulating Eosinophils in Atopic Dermatitis.

  2025cites this paper
• Siglec-8 as a Biomarker for Predicting Anti-IL-5 Response in Severe Asthma

  2025cites this paper
• Current and future therapeutics targeting mast cells in disease.

  2025cites this paper
• Eosinophils in inflammatory bowel disease pathogenesis: an ROS-centric view

  2025cites this paper
• From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis

  2024cites this paper
• Optimizing Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders

  2024cites this paper
• Krankheitsaktivität und Therapie regelmäßig reevaluieren

  2024cites this paper
• Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis

  2024cites this paper
• Vectorized Human Antibody-Mediated Anti-Eosinophil Gene Therapy

  2024cites this paper
• The Association of Blood Eosinophils and Neutrophils Expressing Eosinophilic Surface Markers with the Severity and Outcome of COVID-19

  2024cites this paper
• The role of mitochondria in eosinophil function: implications for severe asthma pathogenesis

  2024cites this paper
• Strategien bei chronischer spontaner Urtikaria

  2024cites this paper
• Chronic spontaneous urticaria—status quo and future

  2023cites this paper
• Eosinophilic gastroenteritis: Pathogenesis, diagnosis, and treatment

  2023cites this paper
• Impact of gold nanoparticles (AuNPs) on eosinophils isolated from male and female individuals.

  2023cites this paper
• Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells

  2023cites this paper
• Chronische spontane Urtikaria - wo stehen wir und wie sieht das Management in Zukunft aus?

  2023cites this paper
• C-type lectin (CTL) and sialic acid-binding lectin (SABL) from Venerupis philippinarum: Function on PAMP binding and opsonic activities in immune responses.

  2023cites this paper
• Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases.

  2023cites this paper
• Eosinophils in obesity and obesity-associated disorders

  2023cites this paper
• Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs

  2023cites this paper
• PFL-lectin regulates the expression of apoptosis-related proteins to antecedent apoptosis in A549 and HT29 cells

  2023cites this paper
• Sequence variety in the CC’ loop of Siglec-8/9/3 determines the recognitions to sulfated oligosaccharides

  2023cites this paper
• Eosinophilic esophagitis: Immune mechanisms and therapeutic targets

  2022cites this paper
• Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances

  2022cites this paper
• Siglecs in allergy and asthma.

  2022cites this paper
• The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

  2022cites this paper
• Siglec-F Promotes IL-33–Induced Cytokine Release from Bone Marrow–Derived Eosinophils Independently of the ITIM and ITIM-like Motif Phosphorylation

  2022cites this paper
• NEUTROPHIL HETEROGENEITY IN SEPSIS: THE ROLE OF DAMAGE-ASSOCIATED MOLECULAR PATTERNS

  2022cites this paper
• Transgenic mouse models to study the physiological and pathophysiological roles of human Siglecs.

  2022cites this paper
• Sialic acid and food allergies: The link between nutrition and immunology

  2022cites this paper
• Perspectives in Therapy of Chronic Rhinosinusitis

  2022cites this paper
• Pharmacological Induction of Granulocyte Cell Death As Therapeutic Strategy.

  2022cites this paper
• Targeting Eosinophils in Mouse Models of Asthma.

  2022cites this paper
• N ANTI -S

  2021cites this paper
• Biologics and Novel Therapies for Food Allergy.

  2021cites this paper
• Induction of the endogenous sialoglycan ligand for eosinophil death receptor Siglec-8 in chronic rhinosinusitis with hyperplastic nasal polyposis.

  2021cites this paper
• A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

  2021cites this paper
• Gene therapy for a murine model of eosinophilic esophagitis

  2021cites this paper
• Chronic urticaria in theory and practice. Experience of UCARE-centers for clinicians

  2021cites this paper
• CD300a contributes to the resolution of articular inflammation triggered by MSU crystals by controlling neutrophil apoptosis

  2021cites this paper
• Targetable pathogenic mechanisms in nasal polyposis

  2021cites this paper
• Siglecs Modulate Activities of Immune Cells Through Positive and Negative Regulation of ROS Generation

  2021cites this paper
• First Evidence for a Role of Siglec-8 in Breast Cancer

  2021cites this paper
• Gene therapy in a murine model of chronic eosinophilic leukemia-not otherwise specified (CEL-NOS)

  2021cites this paper
• Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death In Vitro

  2021cites this paper
• Nanoparticles Displaying Allergen and Siglec-8 Ligands Suppress IgE-FcεRI–Mediated Anaphylaxis and Desensitize Mast Cells to Subsequent Antigen Challenge

  2021cites this paper
• Study on the Critical Roles of Apoptosis in Asthma Disease

  2021cites this paper
• Immunological background for treatments with biologicals in CRSwNP

  2021cites this paper
• A FACS-based approach to obtain viable eosinophils from human adipose tissue

  2020cites this paper
• Granulocyte death mediated by specific antibodies in intravenous immunoglobulin (IVIG).

  2020cites this paper
• Targeting Mast Cells with Biologics.

  2020cites this paper
• An anti‐siglec‐8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells

  2020cites this paper
• Study of Eosinophil Apoptosis Induced by Fasciola hepatica Excretory-Secretory Products.

  2020cites this paper
• Eosinophils in the Tumor Microenvironment.

  2020cites this paper
• Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine

  2020cites this paper
• A Potent Mimetic of the Siglec‐8 Ligand 6’‐Sulfo‐Sialyl Lewisx

  2020cites this paper
• Eosinophil diversity in asthma.

  2020cites this paper
• Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec‐8 instead of endogenous Siglec‐F: Mechanisms and pitfalls

  2020cites this paper
• The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression

  2020cites this paper
• Eosinophil and mast cell Siglecs: From biology to drug target

  2020cites this paper
• Siglecs as Immune Cell Checkpoints in Disease.

  2020influential citation
• Promoter region single nucleotide polymorphism of siglec-8 gene associates with susceptibility to allergic asthma.

  2020cites this paper
• Apoptosis of Eosinophil Granulocytes

  2020cites this paper
• Discovery, Function, and Therapeutic Targeting of Siglec-8

  2020cites this paper
• Emerging mechanisms contributing to mast cell-mediated pathophysiology with therapeutic implications.

  2020cites this paper
• Current and EmergingTreatments for Chronic Spontaneous Urticaria.

  2020cites this paper
• Influenza A virus directly modulates mouse eosinophil responses

  2020cites this paper
• The role of Siglec-F as a regulator of alveolar macrophage function and adaptation

  2020cites this paper
• Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action

  2019cites this paper
• MicroRNA-215: From biology to theranostic applications.

  2019cites this paper
• Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses

  2019cites this paper
• Targeting cell signaling in allergic asthma

  2019cites this paper
• The sialoglycan-Siglec glyco-immune checkpoint – a target for improving innate and adaptive anti-cancer immunity

  2019cites this paper
• Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.

  2019cites this paper
• Immune recognition, antimicrobial and opsonic activities mediated by a sialic acid binding lectin from Ruditapes philippinarum.

  2019cites this paper
• Emerging Therapies in Chronic Spontaneous Urticaria

  2019cites this paper
• Siglec‐7 on peripheral blood eosinophils: Surface expression and function

  2019cites this paper
• AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice

  2019cites this paper
• Sialic Acid-Binding Lectins as Potential Pathophysiological Targets in Treatment of Chronic Bronchopulmonary Diseases (Review)

  2019cites this paper
• Siglec‐F is induced by granulocyte–macrophage colony‐stimulating factor and enhances interleukin‐4‐induced expression of arginase‐1 in mouse macrophages

  2019cites this paper
• Allergy and Atopic Diseases: An Update on Experimental Evidence

  2019cites this paper
• Siglec-8 in eosinophilic disorders: receptor expression and targeting using chimeric antibodies

  2019cites this paper
• Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways

  2018cites this paper
• Siglec‐8 on murine eosinophils: A new model for an old target

  2018cites this paper
• Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge

  2018cites this paper
• Novel eosinophilic gene expression networks associated with IgE in two distinct asthma populations

  2018cites this paper
• Sialic Acid and Its Role in Immune Regulation

  2018cites this paper
• Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes

  2018cites this paper
• Airway glycomic and allergic inflammatory consequences resulting from keratan sulfate galactose 6-O-sulfotransferase (CHST1) deficiency

  2018cites this paper
• Therapeutic antibodies: A new era in the treatment of respiratory diseases?

  2018cites this paper
• Immunologie der Polyposis nasi als Grundlage für eine Therapie mit Biologicals

  2018cites this paper
• Identification of a Siglec-F+ granulocyte-macrophage progenitor

  2018cites this paper
• Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice

  2018cites this paper
• Chapter 10 Eosinophilic Esophagitis

  2018cites this paper
• Expression of Siglec-8 is regulated by interleukin-5, and serum levels of soluble Siglec-8 may predict responsiveness of severe eosinophilic asthma to mepolizumab.

  2018cites this paper